Modigene Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1.
| Website | http://www.modigeneinc.com |
| Revenue | $5.4 million |
| Employees | View employees |
| Address | 3 Sapir St Weizmann Science Park, Ness Ziona, Central District, IL |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Johnson & Johnson, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Regeneron, Moderna Therapeutics, Novavax +50 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Modigene Inc. employee's phone or email?
Modigene Inc. Questions
The Modigene Inc. annual revenue was $5.4 million in 2026.
Modigene Inc. is based in Ness Ziona, Central District.
The NAICS codes for Modigene Inc. are [325, 3254, 32].
The SIC codes for Modigene Inc. are [283, 28].
